PAI, Sanofi
PAI Partners to Raise Offer for Sanofi’s Consumer Unit
PAI Partners has submitted an improved offer for Sanofi’s consumer health business, according to people familiar with the matter, a potential twist to one of the biggest deals in Europe this year.
PAI Partners makes higher offer for Sanofi's Opella, source says
A consortium led by French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's consumer health business Opella, a source close to the matter said on Thursday, confirming reports in French media.
PAI Partners submits improved bid for Sanofi’s consumer unit
PAI partners has submitted an improved bid for Sanofi’s consumer health business, in an attempt to re-enter the race for what could be one of the pharma industry’s biggest deals this year.
PAI Partners raises offer for Sanofi's consumer unit - reports
PAI Partners raises offer for Sanofi's consumer health unit, Opella, by €200 million and aims to keep key operations in France.
Sanofi 'surprised' by PAI Partners' raised bid for Opella unit
PARIS (Reuters) -French drugmaker Sanofi said on Thursday it was "surprised" by a renewed, higher offer for its consumer arm Opella from private equity firm PAI Partners, saying the move came after the bidding deadline for the business had passed.
PAI Partners Raises Offer For Sanofi's Consumer Health Biz Opella: Reports
A consortium led by French private equity firm PAI Partners has submitted an increased offer for Sanofi's (SASY) consumer health
CD&R Nears Sanofi OTC Deal After Signing With Government
Clayton Dubilier & Rice is nearing a deal to acquire control of Sanofi’s consumer health unit after the American buyout firm ...
France's PAI Partners Ups Bid for Sanofi's Consumer Health Division As French Government Hints Possible Regulatory Block
Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...
France says it has received assurances over sale of painkiller maker to US investment fund CD&R
The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...
PAI Partners Submits Improved Bid on Sanofi's Consumer Unit
PAI partners submitted an improved bid for Sanofi's consumer health business, in an attempt to reenter the race for what could be one of the pharma industry's biggest deals this year.
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare ...